Fei Wang1, Yupei Zhang1, Mengxiao Liu2, and Juan Zhu1
1Department of MRI,AnQing Municipal Hospital, Anqing, China, 2MR scientific Marketing, Diagnostic Imaging, Siemens Healthcare Ltd, Shanghai, China
Synopsis
In
this study, pre- and post-contrast T1-mapping technique and DWI were used for
differential diagnosis of hepatic cyst, hemangioma and HCC. pre- and post-contrast
T1 value, the decrease rate of T1
value and ADC value of the three types of lesions were compared and analyzed.T1-mapping
technology for differential diagnosis of hepatic cyst,hemangioma
and HCC provides a new quantitative method, especially for no-enhanced T1-mapping,
have promise of clinical application.
Purpose
To investigate the performence of T1
relaxation time and diffusion-weighted imaging (DWI) on 3T MRI in distinguishing liver cyst, hemangiomas and hepatocellular carcinoma (HCC).Materials and Methods
160
liver lesions (65 liver cysts, 60 hemangiomas and 35 HCC) were collected from
100 patients with a lesion diameter of more than 8mm. Data acquisitions were
performed on a 3T MR scanner (Magnetom Skyra, Siemens Healthcare, Erlangen,
Germany) with an 18-channel phased array coil. T1-mapping including B1 field calibration
sequence (scan time 10s) and double-flip Angle (3o, 15o) 3D
volumetric interpolated breath-hold examination (VIBE) sequence (scan
time 18s)
was applied before and 5 min after the injection of Gd-DTPA-BMA. pre- and post-contrast
T1 value and ADC value were measured respectively, and the decrease rate of T1 value was calculated. One-way ANOVA
analysis and ROC curve was applied to compare pre- and post-contrast T1 value,decrease
rate of T1 value and ADC value, and intra-group correlation
(ICC) analysis was performed for T1 value and ADC value pre- and post-contrast.Results
In 3T
MRI, T1 value pre-contrast of liver cyst,
hemangioma and HCC was 2720.4±157.03, 1645.66±69.72 and 1375.21±47.2ms,
respectively. T1 value post-contrast was 2232.23±127.85,
285.84±15.1 and 425.71±20.01ms, respectively, with a decrease rate was 17.25%, 81.6%
and 68.84%, respectively. ADC value(×10-3mm2/s)
of liver cyst, hemangioma and HCC was 2.61±0.98, 1.58±0.9 and 0.98±0.42,
respectively. pre- and post-contrast,
T1 value, the decrease rate of
T1 value and ADC value were significantly different in liver cyst, hemangioma
and HCC(p<0.001).In the
comparison between liver cyst and hemangioma, the ROC diagnostic boundary
values of pre- and post-contrast T1 value and ADC value
were 1780ms, 270ms and 1.492×10-3mm2/s, respectively,
which had high sensitivity and specificity for the diagnosis of hemangioma. In
the comparison between hemangioma and HCC, when pre-contrast T1 value and ADC
value ROC diagnostic boundary value of were 1100ms and 0.97×10-3mm2/s,
respectively, they had high sensitivity and specificity for the diagnosis of
liver cancer, while post-contrast T1 value had poor differential diagnostic
efficacy. Pre-contrast T1 and ADC values were highly consistent in the
identification of hemangioma and liver cyst (ICC=0.93), hemangioma and HCC(ICC=0.965),
respectively.Discussion and Conclusion
Except
routine scan and dynamic contrast enhancement, DWI is one of the most important
diagnostic methods for liver diseases. T1-mapping technology has the advantages
of short scan time and can be quantitative analysis, it can make up for the DWI
in the differential diagnosis of liver cyst and hemangioma part insufficient.
What’s more, T1-mapping has better diagnostic efficiency before injection than
post injection, thus avoiding unnecessary increase contrast agent used. It has
potential clinical application value in the differential diagnosis of liver cyst, hemangioma and HCC.Acknowledgements
No acknowledgement found.References
- Ding Y, Rao SX, Chen Cel,et al.Assessing liver function
in patients with HBV-related HCC: a comparison of T₁ mapping on
Gd-EOB-DTPA-enhanced MR imaging with DWI.Eur Radiol,2015,25(5):1392-1398.
- Yoshimura N, Saito K, Saguchi T,et al.Distinguishing hepatic hemangiomas from metastatic tumors using T1 mapping on gadoxetic-acid-enhanced MRI.Magn Reson Imaging,2013,31(1):23-27.